February 24, 2015

Shire on Tuesday acquired Meritage, which includes the phase 3-ready compound Oral Budesonide Suspension for the treatment of adolescents and adults with eosinophilic esophagitis.

February 24, 2015

According to the latest Walgreens Flu Index, flu activity is no longer picking up across the West Coast and in Texas. 

February 23, 2015

The Centers for Disease Control and Prevention last week reported several influenza hot spots across the nation. 

February 23, 2015

A centralized notification system for immunization reminders would significantly improve childhood immunization rates, according to a study pubished in  JAMA Pediatrics

February 23, 2015

Valeant Pharmaceuticals bolsters GI franchise in a $14.5 billion deal to acquire Salix Pharmaceuticals. 

February 20, 2015

The recently introduced Ensuring Patient Access and Effective Drug Enforcement Act of 2015 receives support from the National Association of Chain Drug Stores.

February 19, 2015

Surescripts on Thursday released a step-by-step video guide targeting both small providers and health systems to enable adoption of electronic prescribing of controlled substances.

February 18, 2015

Actavis on Wednesday announced that it will adopt a new corporate name — Allergan — following the anticipated, successful completion of the acquisition of Allergan.

February 18, 2015

Lupin Pharmaceuticals on Wednesday launched the InspiraChamber Anti-Static Valved Holding Chamber for respiratory medicines under a strategic licensing agreement with InspiRX.

February 18, 2015

PatientsLikeMe and Walgreens are trying to make it easier for people to understand how the medications they take may affect them.

 

February 17, 2015

The Food and Drug Administration has approved Lenvima (lenvatinib) for the treatment of differentiated thyroid cancer. 

February 17, 2015

The flu is making its way to the Southeastern United States, according to the latest Walgreens Flu Index.

February 12, 2015

Sens. Orrin Hatch, R-Utah, and Sheldon Whitehouse, D-R.I., on Thursday introduced companion legislation to House bill H.R. 471.

 

February 10, 2015

From Jan. 1 to Feb. 6, 2015, 121 people from 17 states and Washington D.C. were reported to have measles.

February 10, 2015

PricewaterhouseCoopers released a new spotlight on the dangers of antimicrobial resistance.

 

February 9, 2015

Under new bipartisan legislation, seniors would have more convenient access to discounted or "preferred" co-pays for prescription drugs at their pharmacy of choice.

February 9, 2015

Daiichi Sankyo on Monday announced that its Savaysa (edoxaban) tablets are now available in pharmacies across the United States. The drug was granted approval from the Food and Drug Administration on Jan. 8 and is used to reduce the risk of stroke and systemic embolism in patients who have a non-valvular atrial fibrillation, as well as for the treatment of deep vein thrombosis and pulmonary embolism, the company said.

February 6, 2015

The pharma industry praised outgoing Food and Drug Administration commissioner Margaret Hamburg and welcomed Stephen Ostroff, who will assume the role of acting commissioner.

February 5, 2015

HDMA recognized four members of Congress with the Association’s Rx Safety and Healthcare Leadership Award.

February 5, 2015

Food and Drug Commissioner Margaret Hamburg will resign from her post in March.

 

February 5, 2015

Merck earlier this week announced that Belsomra (suvorexant) is now available at pharmacies in the United States for the treatment of insomnia.

February 5, 2015

Pfizer has entered into a definitive merger agreement to acquire Hospira.

 

February 5, 2015

Generic drug prices are going up. Spurred by market opportunities, short-term market exclusivity for some newly launched single-source generics and rising costs for manufacturing, quality control and raw materials, me-too drug manufacturers have escalated a series of price hikes, some of them significant.

February 3, 2015

Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Co. on Monday announced that the Food and Drug Administration has approved Glyxambi (empagliflozin/linagliptin) tablets.